InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Danos Olivier, Directeur Scientifique. Officer active across 1 company, notably REGENXBIO Inc.. Aggregated, 6 disclosures have been published. Activity tracked since 30 June 2021. The latest transaction was filed on 1 February 2025 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Danos Olivier is Directeur Scientifique and Chief Scientific Officer at REGENXBIO Inc. He has 6 filings in total, and across the 6 recent filings observed, the transactions are for tax withholding, with a date range from 2022-01-04 to 2025-04-04.